Department of Defense Recommends Soldiers Carry WoundStat for Life-Threatening Bleeding


June 11, 2008

June 11, 2008 - TraumaCure Inc. said last week the DOD Joint Committee on Tactical Combat Casualty Care (CoTCCC) recommended U.S. soldiers from all services carry the company’s hemostatic agent, WoundStat.

The CoTCCC based its recommendations on the results of extensive studies conducted by both the army’s Institute for Surgical Research (ISR) and the Naval Medical Research Center (NMRC). In those studies, no other product was as effective across the board in terms of survival, post treatment blood loss, and duration of hemostasis.

This is the first time ever that all branches of the military have come together and jointly recommended the same product for the most severe injuries involving high-pressure bleeding.

“Severe bleeding is the number one cause of death for soldiers injured in battle. The ISR study clearly shows WoundStat works consistently to stop serious bleeding quickly. In light of these study results, WoundStat will be a critical product in the field available to all soldiers in harm’s way, where and when it is needed most,” said Ron Blanck, retired U.S. Army surgeon general. “Approximately 80 percent of injuries in the current conflict are from improvised explosive devices (IEDs), which result in the severe and irregular wounds that WoundStat is specifically designed to treat. In those situations, WoundStat works in seconds, not minutes.”

Four different studies - including the one conducted by the army’s ISR, along with others conducted at Virginia Commonwealth University, the Air Force, and NAMSA - have proven WoundStat is one of the most effective hemostat available for high-pressure arterial wounds. In each of these studies, WoundStat was the only product that resulted in 100 percent survival. The wound treatment works through standing blood and has the added advantage that, should re-bleeding occur, a wound can be re-packed with the WoundStat already present, a big advantage in combat conditions.

TraumaCure has enough WoundStat in stock to equip every soldier currently deployed in the Middle East theater. The cost of WoundStat is about one-third that of the product the army has been using for the past several years. WoundStat is also available for domestic use by emergency responders and others who need to be prepared for treating traumatic injuries.

For more information: